Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis

Overview of attention for article published in Frontiers in immunology, August 2023

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (72nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

So far, Altmetric has seen 13 X posts from 12 X users, with an upper bound of 43,967 followers.

RT @FrontImmunol: New Research: Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated…

RT @mjuanfi81: Metanalysis. 47 studies. 11.491 cancer patients treated with ICI Lower baseline NLR was associated with increased irAES (OR…

RT @mjuanfi81: Metanalysis. 47 studies. 11.491 cancer patients treated with ICI Lower baseline NLR was associated with increased irAES (OR…

RT @FrontImmunol: New Research: Neutrophil to Lymphocyte ratio as a predictor for immune-related adverse events in cancer patients treated…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.